Log in

NASDAQ:RTRXRetrophin News Headlines

$16.27
+0.48 (+3.04 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$15.67
Now: $16.27
$16.41
50-Day Range
$13.46
MA: $15.62
$16.74
52-Week Range
$8.98
Now: $16.27
$21.95
Volume312,771 shs
Average Volume375,975 shs
Market Capitalization$702.21 million
P/E RatioN/A
Dividend YieldN/A
Beta0.81

Headlines

Retrophin (NASDAQ RTRX) News Headlines

Source:
DateHeadline
Retrophin Inc (NASDAQ:RTRX) Expected to Announce Quarterly Sales of $48.50 MillionRetrophin Inc (NASDAQ:RTRX) Expected to Announce Quarterly Sales of $48.50 Million
www.americanbankingnews.com - May 30 at 3:43 AM
Black Womens Health Imperative Announces New Rare Disease Diversity Coalition - Yahoo FinanceBlack Women's Health Imperative Announces New Rare Disease Diversity Coalition - Yahoo Finance
finance.yahoo.com - May 29 at 12:00 PM
Canopy Growth (CGC) to Report Q4 Earnings: Whats in Store? - NasdaqCanopy Growth (CGC) to Report Q4 Earnings: What's in Store? - Nasdaq
www.nasdaq.com - May 28 at 12:37 PM
Retrophin to Present at the Jefferies 2020 Virtual Healthcare Conference - GlobeNewswireRetrophin to Present at the Jefferies 2020 Virtual Healthcare Conference - GlobeNewswire
www.globenewswire.com - May 28 at 1:07 AM
Retrophin to Present at the Jefferies 2020 Virtual Healthcare ConferenceRetrophin to Present at the Jefferies 2020 Virtual Healthcare Conference
finance.yahoo.com - May 27 at 8:07 PM
Retrophin Inc (NASDAQ:RTRX) Given Average Rating of "Buy" by BrokeragesRetrophin Inc (NASDAQ:RTRX) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - May 27 at 2:49 AM
Pharma fraudster Martin Shkreli denied prison release after he said he could help find coronavirus treatment - CNBCPharma fraudster Martin Shkreli denied prison release after he said he could help find coronavirus treatment - CNBC
www.cnbc.com - May 20 at 4:40 AM
Retrophins (RTRX) Buy Rating Reiterated at Canaccord GenuityRetrophin's (RTRX) Buy Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - May 19 at 10:45 AM
Focal Segmental Glomerulosclerosis (FSGS) Market Insight, Epidemiology and Forecast to 2030 - ResearchAndMarkets.com - Yahoo FinanceFocal Segmental Glomerulosclerosis (FSGS) Market Insight, Epidemiology and Forecast to 2030 - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - May 18 at 12:29 PM
SVB Leerink Equities Analysts Lift Earnings Estimates for Retrophin Inc (NASDAQ:RTRX)SVB Leerink Equities Analysts Lift Earnings Estimates for Retrophin Inc (NASDAQ:RTRX)
www.americanbankingnews.com - May 15 at 9:01 AM
Retrophin Inc to Post Q2 2020 Earnings of ($0.63) Per Share, William Blair Forecasts (NASDAQ:RTRX)Retrophin Inc to Post Q2 2020 Earnings of ($0.63) Per Share, William Blair Forecasts (NASDAQ:RTRX)
www.americanbankingnews.com - May 15 at 9:01 AM
Insider Selling: Retrophin Inc (NASDAQ:RTRX) Director Sells 3,062 Shares of StockInsider Selling: Retrophin Inc (NASDAQ:RTRX) Director Sells 3,062 Shares of Stock
www.americanbankingnews.com - May 14 at 11:50 PM
Steve Aselage Sells 1,000 Shares of Retrophin Inc (NASDAQ:RTRX) StockSteve Aselage Sells 1,000 Shares of Retrophin Inc (NASDAQ:RTRX) Stock
www.americanbankingnews.com - May 14 at 11:50 PM
Retrophin Inc (NASDAQ:RTRX) CFO Laura Clague Sells 1,250 SharesRetrophin Inc (NASDAQ:RTRX) CFO Laura Clague Sells 1,250 Shares
www.americanbankingnews.com - May 14 at 5:40 AM
Edited Transcript of RTRX earnings conference call or presentation 11-May-20 8:30pm GMT - Yahoo FinanceEdited Transcript of RTRX earnings conference call or presentation 11-May-20 8:30pm GMT - Yahoo Finance
finance.yahoo.com - May 12 at 3:20 PM
Retrophin (RTRX) Q1 2020 Earnings Call Transcript - Motley FoolRetrophin (RTRX) Q1 2020 Earnings Call Transcript - Motley Fool
www.fool.com - May 12 at 3:20 PM
Edited Transcript of RTRX earnings conference call or presentation 11-May-20 8:30pm GMTEdited Transcript of RTRX earnings conference call or presentation 11-May-20 8:30pm GMT
finance.yahoo.com - May 12 at 3:20 PM
Retrophin (RTRX) Tops Q1 Earnings and Revenue Estimates - Yahoo FinanceRetrophin (RTRX) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
finance.yahoo.com - May 11 at 10:40 PM
Retrophin (RTRX) Tops Q1 Earnings and Revenue EstimatesRetrophin (RTRX) Tops Q1 Earnings and Revenue Estimates
finance.yahoo.com - May 11 at 10:40 PM
Retrophin Reports First Quarter 2020 Financial Results Nasdaq:RTRX - GlobeNewswireRetrophin Reports First Quarter 2020 Financial Results Nasdaq:RTRX - GlobeNewswire
www.globenewswire.com - May 11 at 5:39 PM
Retrophin Reports First Quarter 2020 Financial ResultsRetrophin Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 11 at 5:39 PM
Prosecutors oppose Martin Shkrelis coronavirus early prison release bid, call him delusional, greedy - CNBCProsecutors oppose Martin Shkreli's coronavirus early prison release bid, call him 'delusional,' greedy - CNBC
www.cnbc.com - April 29 at 2:27 PM
Retrophin to Report First Quarter 2020 Financial Results - GlobeNewswireRetrophin to Report First Quarter 2020 Financial Results - GlobeNewswire
www.globenewswire.com - April 27 at 8:54 PM
Retrophin to Report First Quarter 2020 Financial ResultsRetrophin to Report First Quarter 2020 Financial Results
finance.yahoo.com - April 27 at 8:54 PM
Coronavirus: Martin Shkreli seeks early prison release to work on Covid-19 treatment, avoid infection - CNBCCoronavirus: Martin Shkreli seeks early prison release to work on Covid-19 treatment, avoid infection - CNBC
www.cnbc.com - April 22 at 5:54 PM
Does Retrophin, Inc. (NASDAQ:RTRX) Have A Volatile Share Price?Does Retrophin, Inc. (NASDAQ:RTRX) Have A Volatile Share Price?
finance.yahoo.com - April 11 at 1:01 PM
Retrophin (RTRX) Adds Suzanne L. Bruhn Ph.D. to Board - StreetInsider.comRetrophin (RTRX) Adds Suzanne L. Bruhn Ph.D. to Board - StreetInsider.com
www.streetinsider.com - April 9 at 5:39 PM
Retrophin Appoints Suzanne L. Bruhn, Ph.D. to Board of Directors - Yahoo FinanceRetrophin Appoints Suzanne L. Bruhn, Ph.D. to Board of Directors - Yahoo Finance
finance.yahoo.com - April 9 at 5:39 PM
Retrophin Appoints Suzanne L. Bruhn, Ph.D. to Board of DirectorsRetrophin Appoints Suzanne L. Bruhn, Ph.D. to Board of Directors
finance.yahoo.com - April 9 at 5:39 PM
Pharma Bro Shkreli wants out of prison to research coronavirus - NBCNews.com'Pharma Bro' Shkreli wants out of prison to research coronavirus - NBCNews.com
www.nbcnews.com - April 8 at 2:32 PM
Michael Hiltzik: Shkreli wants out of prison to help with coronavirus - Los Angeles TimesMichael Hiltzik: Shkreli wants out of prison to help with coronavirus - Los Angeles Times
www.latimes.com - April 7 at 4:31 PM
ADC Therapeutics to Appoint Ron Squarer as Chairman of Its Board of Directors and an Advisor to the Company - Yahoo FinanceADC Therapeutics to Appoint Ron Squarer as Chairman of Its Board of Directors and an Advisor to the Company - Yahoo Finance
finance.yahoo.com - March 19 at 7:53 AM
Do Options Traders Know Something About Retrophin (RTRX) Stock We Dont? - Yahoo FinanceDo Options Traders Know Something About Retrophin (RTRX) Stock We Don't? - Yahoo Finance
finance.yahoo.com - March 19 at 12:29 AM
Do Options Traders Know Something About Retrophin (RTRX) Stock We Dont? - NasdaqDo Options Traders Know Something About Retrophin (RTRX) Stock We Don't? - Nasdaq
www.nasdaq.com - March 18 at 7:28 PM
Do Options Traders Know Something About Retrophin (RTRX) Stock We Don't?Do Options Traders Know Something About Retrophin (RTRX) Stock We Don't?
finance.yahoo.com - March 18 at 2:27 PM
Ligand’s Presentation at the Barclays Global Healthcare Conference Now a Webcast Only, New Slides Available on Ligand.com - Yahoo FinanceLigand’s Presentation at the Barclays Global Healthcare Conference Now a Webcast Only, New Slides Available on Ligand.com - Yahoo Finance
finance.yahoo.com - March 11 at 9:16 AM
Retrophin (RTRX) Reports Enrollment of First 190 Patients in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis - StreetInsider.comRetrophin (RTRX) Reports Enrollment of First 190 Patients in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis - StreetInsider.com
www.streetinsider.com - March 9 at 7:07 PM
Retrophin Announces Enrollment of First 190 Patients in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis - GlobeNewswireRetrophin Announces Enrollment of First 190 Patients in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis - GlobeNewswire
www.globenewswire.com - March 9 at 8:57 AM
Retrophin Announces Enrollment of First 190 Patients in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental GlomerulosclerosisRetrophin Announces Enrollment of First 190 Patients in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis
finance.yahoo.com - March 9 at 8:57 AM
Retrophin Recognizes Rare Disease Day 2020 and the Importance of Working Together Toward More Equitable Access to Care - GlobeNewswireRetrophin Recognizes Rare Disease Day 2020 and the Importance of Working Together Toward More Equitable Access to Care - GlobeNewswire
www.globenewswire.com - February 29 at 9:55 AM
Retrophin Recognizes Rare Disease Day 2020 and the Importance of Working Together Toward More Equitable Access to Care - Yahoo FinanceRetrophin Recognizes Rare Disease Day 2020 and the Importance of Working Together Toward More Equitable Access to Care - Yahoo Finance
finance.yahoo.com - February 28 at 12:21 PM
Retrophin Recognizes Rare Disease Day 2020 and the Importance of Working Together Toward More Equitable Access to CareRetrophin Recognizes Rare Disease Day 2020 and the Importance of Working Together Toward More Equitable Access to Care
finance.yahoo.com - February 28 at 12:21 PM
Edited Transcript of RTRX earnings conference call or presentation 24-Feb-20 9:30pm GMT - Yahoo FinanceEdited Transcript of RTRX earnings conference call or presentation 24-Feb-20 9:30pm GMT - Yahoo Finance
finance.yahoo.com - February 25 at 1:09 PM
Why Fuel Cell Stocks Dropped Like a Rock Today - NasdaqWhy Fuel Cell Stocks Dropped Like a Rock Today - Nasdaq
www.nasdaq.com - February 25 at 8:08 AM
Oceaneering International Inc. Q4 adjusted earnings of $0.03 per share - NasdaqOceaneering International Inc. Q4 adjusted earnings of $0.03 per share - Nasdaq
www.nasdaq.com - February 25 at 8:08 AM
Retrophin, Inc. (RTRX) CEO Eric Dube on Q4 2019 Results - Earnings Call Transcript - Seeking AlphaRetrophin, Inc. (RTRX) CEO Eric Dube on Q4 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 25 at 8:08 AM
Retrophin (RTRX) Q4 2019 Earnings Call Transcript - Motley FoolRetrophin (RTRX) Q4 2019 Earnings Call Transcript - Motley Fool
www.fool.com - February 25 at 8:08 AM
Edited Transcript of RTRX earnings conference call or presentation 24-Feb-20 9:30pm GMTEdited Transcript of RTRX earnings conference call or presentation 24-Feb-20 9:30pm GMT
finance.yahoo.com - February 25 at 8:08 AM
Retrophin Reports Fourth Quarter and Full Year 2019 Financial Results - GlobeNewswireRetrophin Reports Fourth Quarter and Full Year 2019 Financial Results - GlobeNewswire
www.globenewswire.com - February 24 at 7:56 PM
Retrophin (RTRX) Tops Q4 EPS by 38c, Revenues Beat - StreetInsider.comRetrophin (RTRX) Tops Q4 EPS by 38c, Revenues Beat - StreetInsider.com
www.streetinsider.com - February 24 at 7:56 PM
This page was last updated on 6/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.